Who owns GRAL? 13F holders and whale ownership
GRAL is tracked across public portfolios in Whale Analyzer. This page answers who owns GRAL, which top funds are buying GRAL, aggregate disclosed value, and recent position changes based on public data.
Open interactive stock dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $208.2M | 4.0M | Increased |
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $22.1M | 428.3K | Held |
| Edgewood Management 13F portfolio Edgewood Management LLC holdings | $516.8K | 10.0K | Held |
How to read this page
Values are reported public positions from tracked investors and institutions. They are not real-time ownership totals for the company.
Related stock holder pages
- INCY whale holders — Incyte Corporation
- BEIGF whale holders — BeOne Medicines Ltd.
- INSM whale holders — Insmed Incorporated
- MDGL whale holders — Madrigal Pharmaceuticals, Inc.
- ACAD whale holders — ACADIA Pharmaceuticals Inc.
- RVMDW whale holders — Revolution Medicines, Inc.
- CELC whale holders — Celcuity Inc.
- KOD whale holders — Kodiak Sciences Inc.
Learn more in Whale Analyzer Academy
Frequently asked questions
Who owns GRAL stock?
Whale Analyzer tracks 3 public institutional holders of GRAL with a combined reported value of $230.8M. See the holder table above for the largest tracked positions.
Which top funds are buying GRAL?
Check the "Change" column in the holders table above. "New" means a fresh position was initiated, "Added" means an existing position was increased, and "Reduced" or "Sold" indicates trimming.
What does 13F ownership mean for GRAL?
Use the interactive GRAL dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.